文献速递细菌感染、耐药与抗菌药物

成功胆道引流后急性菌血症性胆管炎缩短抗生素疗程:一项回顾性队列研究

Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study.
PubMed 文献 · Clin Microbiol Infect · 2018-03-07

该单中心回顾性队列研究纳入日本263例成功胆道引流的急性菌血症性胆管炎患者,比较短疗程(≤7天)与长疗程(≥8天)抗菌治疗,主要终点为30天死亡率。短疗程组30天死亡率为4.7%(4/85),长疗程组为5.7%(10/176),p=1.00;倾向评分分析亦未显示两组差异。作者认为,成功胆道引流后缩短抗菌疗程可能是合理选择。

要点

  • 短疗程(≤7天)与长疗程(≥8天)抗菌治疗30天死亡率无显著差异。
  • 短疗程组中位疗程6天,长疗程组中位疗程12天。
  • 倾向评分分析未显示两组在30天死亡率或复合结局上有差异。

核心结论

  • 中位疗程6天的短疗程抗菌治疗与中位疗程12天的长疗程治疗相比,结局不更差。
  • 成功胆道引流后缩短抗菌治疗疗程可能是治疗急性菌血症性胆管炎的合理选择。

研究设计与样本

  • 日本单中心回顾性队列研究。
  • 纳入263例成功胆道引流的急性菌血症性胆管炎患者,短疗程组86例(32.7%),长疗程组177例(67.3%)。
  • 比较短疗程(≤7天)与长疗程(≥8天)抗菌治疗,主要终点为30天死亡率。
  • 构建Logistic回归模型分析死亡率和复合结局,并采用倾向评分逆概率加权分析。

主要发现

  • 短疗程组中位疗程6天(范围2-7天),长疗程组中位疗程12天(范围8-46天)。
  • 短疗程组30天死亡率为4.7%(4/85),长疗程组为5.7%(10/176),p=1.00。
  • Logistic回归显示短疗程组30天死亡率OR为1.07(95%CI 0.25-4.52,p=0.93),复合结局OR为1.08(95%CI 0.48-2.45,p=0.85)。
  • 倾向评分分析显示两组30天死亡率和复合结局均无差异(p=0.65和p=0.95)。

关键数值与推荐

  • 短疗程定义为≤7天,长疗程定义为≥8天。
  • 复合结局包括死亡、复发、再燃、新发菌血症、肝脓肿或其他胆管炎相关并发症。

临床怎么用

  • 作者认为,成功胆道引流后缩短抗菌治疗疗程可能是治疗急性菌血症性胆管炎的合理选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the effectiveness of short duration antimicrobial therapy for acute cholangitis with bacteraemia. METHODS: We conducted a retrospective cohort study of patients with acute bacteraemic cholangitis with successful biliary duct drainage at a single centre in Japan. We compared short-course antimicrobial therapy (SCT, ≤7 days) and long-course therapy (LCT, ≥8 days), with a primary outcome of 30-day mortality. We constructed logistic regression models for mortality and a composite outcome, including mortality, recurrence, recrudescence, new bacteraemia, liver abscess or other complications related to cholangitis. We also developed a propensity score for SCT with inverse probability weighting for both the primary outcome and the composite outcome. RESULTS: We identified 263 patients in our cohort; 86 (32.7%) patients received SCT and the remaining 177 (67.3%) received LCT. The median durations of SCT and LCT were 6 days (range 2-7 days) and 12 days (range 8-46 days), respectively. The 30-day mortalities of SCT and LCT were 4.7% (4/85) and 5.7% (10/176), respectively (p 1.00). Logistic regression analysis showed that the odds ratio of SCT for 30-day mortality and the composite outcome were 1.07 (95% CI 0.25-4.52, p 0.93) and 1.08 (95% CI 0.48-2.45, p 0.85), respectively. Propensity score analyses for both 30-day mortality and the composite outcome did not demonstrate a difference between SCT and LCT (p 0.65 and p 0.95, respectively). CONCLUSIONS: SCT with a median duration of 6 days did not have worse outcomes than LCT with a median duration of 12 days. Shortening the duration of antimicrobial therapy may be a reasonable option when treating acute bacteraemic cholangitis following successful biliary drainage.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Doi A, Morimoto T, Iwata K, et al. Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect. 2018. PMID: 29408612. doi:10.1016/j.cmi.2018.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。